CAJ | 학술논문

睑板腺功能障碍(meibomian gland dysfunction,MGD)是一种常见的眼表疾病,是多种睑板腺异常的总称,包括其结构异常和分泌物性质的异常,可引起眼睑炎症和泪液不稳定以及其他眼表疾病,其中最常见的病变是后部睑缘炎和脂质缺乏性(lipid tear deficiency,LTD)干眼症.既往MGD的治疗主要为眼睑清洁、热敷、睑板腺按摩、营养治疗、激素以及抗生素应用等,近年来物理疗法、免疫调节、环境调节等治疗方法有了新的进展,抗生素的治疗机理研究也有新的发现.
검판선공능장애(meibomian gland dysfunction,MGD)시일충상견적안표질병,시다충검판선이상적총칭,포괄기결구이상화분비물성질적이상,가인기안검염증화루액불은정이급기타안표질병,기중최상견적병변시후부검연염화지질결핍성(lipid tear deficiency,LTD)간안증.기왕MGD적치료주요위안검청길、열부、검판선안마、영양치료、격소이급항생소응용등,근년래물리요법、면역조절、배경조절등치료방법유료신적진전,항생소적치료궤리연구야유신적발현.
Meibomian gland dysfunction (MGD) is the general term that describes a chronic,diffuse abnormality of the meibomian glands,commonly characterized by terminal duct obstruction or/and qualitative and quantitative changes in the meibom secretion.It may result in instability of the tear film,inflammation in the lid margin,lipid tear deficiency(LTD) dry eye and other ocular surface diseases.Previously,MGD treatment includes the eyelids cleaning,warm massage,nutritional therapy,hormone and antibiotic applications.In recent years,physical therapy,immune regulation,and environmental regulation,as well as the study of the mechanism of antibiotic application,has a lot of new progresses.